Series A Biotechnology Companies

Find therapeutics is operator of a drug discovery and development company intended to emerge with a new therapeutic modality.

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

Light Horse Therapeutics is a small molecule drug discovery, pioneering to target that causes disabling and life-threatening diseases.

Verdiva Bio creates cutting-edge treatments that improve results for patients with obesity and cardiometabolic diseases.

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

LinKinVax operates as a clinical-stage biotechnology company.

Aethon Therapeutics treats cancer by combining immunotherapy and targeted treatment to increase its effectiveness.

Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.

Engitix is operates as a tissue engineering company.

Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.

Corsera Health develops preventive RNA interference medicines that reduces cardiovascular disease risk before long-term damage occurs.

Spiro Medical is a medical device company developing a groundbreaking Pulmonary Neuromodulation (PNM) System for asthma treatment.

Luminate Medical develops a medical device designed to prevent hair loss during chemotherapy.

Stream Biomedical is a product development company that focuses on developing neuroprotective and neuroreparative therapies.

AvengeBio is focusing on Cell-Generated Immunotherapies to eradicate solid tumors.

Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.

Belharra Therapeutics disrupts the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform.

Intrance Medical Systems is a biopharmaceutical company.

Amberstone Biosciences discovers novel immunotherapies through innovative technologies and creative partnerships.

ENB Therapeutics develops therapies to break barriers that prevent the majority of patients from responding to immunotherapy agents.

Gandeeva’s proprietary platform provides a rational, cryo-EM- and AI-driven approach for the design of potent molecular glues.

Ribbon Bio defines new standards for molecular biology by applying innovative methods for DNA synthesis.

Pranax is a biotechnology company that develops and commercializes regenerative medicine solutions centered on exosome technology.

Breakthru Medicine develops novel therapeutic modalities aimed at treating cancer by targeting hard-to-drug disease mechanisms.

Tensive is a biomedical startup established in 2012 to develop innovative prostheses aiming to substitute silicone implants.